Therma Bright (TSE:THRM) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Therma Bright Inc. celebrates the successful initial clinical trial results of the PREVA™ ischemic stroke device, developed by its investment partner Inretio, which were presented at the BRAIN Conference 2024. The device promises to revolutionize stroke care by improving patient recovery outcomes, marking a significant milestone for Inretio’s clinical program.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money